Continuous glucose monitoring and U.S. market strategy
Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2014.
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | eng |
| Published: |
Massachusetts Institute of Technology
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1721.1/90224 |
| _version_ | 1826217636243963904 |
|---|---|
| author | Sharma, Shweta Humad |
| author2 | Robert Pindyck. |
| author_facet | Robert Pindyck. Sharma, Shweta Humad |
| author_sort | Sharma, Shweta Humad |
| collection | MIT |
| description | Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2014. |
| first_indexed | 2024-09-23T17:06:50Z |
| format | Thesis |
| id | mit-1721.1/90224 |
| institution | Massachusetts Institute of Technology |
| language | eng |
| last_indexed | 2024-09-23T17:06:50Z |
| publishDate | 2014 |
| publisher | Massachusetts Institute of Technology |
| record_format | dspace |
| spelling | mit-1721.1/902242019-04-11T00:22:09Z Continuous glucose monitoring and U.S. market strategy CGM and U.S. market strategy Sharma, Shweta Humad Robert Pindyck. Sloan School of Management. Sloan School of Management. Sloan School of Management. Thesis: M.B.A., Massachusetts Institute of Technology, Sloan School of Management, 2014. Cataloged from PDF version of thesis. Includes bibliographical references. There are about 25M (million) diabetics in the US alone, of which only 5-10% of the type 1 diabetics (1M) market has been penetrated with continuous glucose monitoring (CGM) devices. This thesis will provide an overview of the glucose monitoring, then focus on who the key market players for CGM are. Ensuing sections will explore product offerings, understanding what features patients care for and what critical limitations exist in design. It will also tackle why there hasn't been a more widespread adoption of CGM systems considering the technology has been on the market for a decade now. It will dive into a variety of potential market drivers, such as, first mover's advantage, pricing, product attributes and reimbursement coverage. It will emphasize the two US leaders, Medtronic and Dexcom and analyze the companies by comparing their revenue and underlying strategies. Finally the thesis will cover emerging technologies that could pose a market threat to incumbents. by Shweta Humad Sharma. M.B.A. 2014-09-19T21:47:05Z 2014-09-19T21:47:05Z 2014 2014 Thesis http://hdl.handle.net/1721.1/90224 890374849 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 24 pages application/pdf n-us--- Massachusetts Institute of Technology |
| spellingShingle | Sloan School of Management. Sharma, Shweta Humad Continuous glucose monitoring and U.S. market strategy |
| title | Continuous glucose monitoring and U.S. market strategy |
| title_full | Continuous glucose monitoring and U.S. market strategy |
| title_fullStr | Continuous glucose monitoring and U.S. market strategy |
| title_full_unstemmed | Continuous glucose monitoring and U.S. market strategy |
| title_short | Continuous glucose monitoring and U.S. market strategy |
| title_sort | continuous glucose monitoring and u s market strategy |
| topic | Sloan School of Management. |
| url | http://hdl.handle.net/1721.1/90224 |
| work_keys_str_mv | AT sharmashwetahumad continuousglucosemonitoringandusmarketstrategy AT sharmashwetahumad cgmandusmarketstrategy |